The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy-Reference-Cited by-同舟云学术

The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy

Published:2015-12 Issue:1 Volume:15 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Kasaian Katayoon,Wiseman Sam M.,Walker Blair A.,Schein Jacqueline E.,Zhao Yongjun,Hirst Martin,Moore Richard A.,Mungall Andrew J.,Marra Marco A.,Jones Steven JM

Funder

Canadian Institutes of Health Research (CA)

Canadian Cancer Society Research Institute (CA)

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-015-1955-9

Reference50 articles.

1. Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012;22(11):1104–39.

2. Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 2005;103(7):1330–5.

3. Sugitani I, Miyauchi A, Sugino K, Okamoto T, Yoshida A, Suzuki S. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg. 2012;36(6):1247–54.

4. Wiseman SM, Loree TR, Hicks Jr WL, Rigual NR, Winston JS, Tan D, et al. Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation by means of the inter-simple sequence repeat polymerase chain reaction. Arch Otolaryngol Head Neck Surg. 2003;129(1):96–100.

5. Ragazzi M, Ciarrocchi A, Sancisi V, Gandolfi G, Bisagni A, Piana S. Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer. Int J Endocrinol. 2014;2014:790834.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alginate/Carboxymethyl Chitosan Core-Shell Microspheres Coloaded with Doxorubicin/Docetaxel Reverse Chemotherapy Resistance in Anaplastic Thyroid Carcinoma;Thyroid®;2024-07-01

2. Promising Therapeutic Targets for Recurrent/Metastatic Anaplastic Thyroid Cancer;Current Treatment Options in Oncology;2024-06-12

3. Synergistic effects of the combination of trametinib and alpelisib in anaplastic thyroid cancer with BRAF and PI3KCA co-mutations;Heliyon;2024-04

4. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma;Cell Reports;2024-03

5. Anaplastic thyroid cancer: Pathogenesis, prognostic factors and genetic landscape (Review);Molecular and Clinical Oncology;2023-11-02